Amyloids, amorphous aggregates and assemblies of peptides – Assessing aggregation.

Amyloid and amorphous aggregates represent the two major categories of aggregates associated with diseases, and although exhibiting distinct features, researchers often treat them as equivalent, which demonstrates the need for more thorough characterization. Here, we compare amyloid and amorphous aggregates based on their biochemical properties, kinetics, and morphological features. To further decipher this issue, we propose the use of peptide self-assemblies as minimalistic models for understanding the aggregation process. Peptide building blocks are significantly smaller than proteins that participate in aggregation, however, they make a plausible means to bridge the gap in discerning the aggregation process at the more complex, protein level. Additionally, we explore the potential use of peptide-inspired models to research the liquid-liquid phase separation as a feasible mechanism preceding amyloid formation. Connecting these concepts can help clarify our understanding of aggregation-related disorders and potentially provide novel drug targets to impede and reverse these serious illnesses. [Display omitted] • Aggregation-related disorders are caused by both amyloids and amorphous species. • Amyloids and amorphous aggregates show distinct characteristics upon aggregation. • Short peptides provide a valuable model in protein aggregation research. • LLPS might help understand the processes underlying amyloid fibrillation. [ABSTRACT FROM AUTHOR]